Its anorexigenic mechanism of action relies on its ability to cross the blood-brain barrier (BBB) and activate the melanocortin four receptor (MC4R)-dependent pathway, one of the most potent currently known regulators of obesity (Mosialou et al., 2017). The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.